Physician profile
Sameer Shakir
NPI 1477930329
$5,349.77
in general payments reported to CMS, 2019-2025
9 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2021: $435 · 2022: $690 · 2023: $2,819 · 2024: $465 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,123 · Travel and Lodging: $1,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,123.36 |
| Travel and Lodging | $1,457.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,960.56 | 2023-2025 | Trumatch |
| Kls-Martin L.P. | $1,022.05 | 2022-2025 | |
| Depuy Synthes Sales INC. | $829.85 | 2021-2025 | Trumatch, Na, Matrixmandible |
| Allergan, INC. | $738.96 | 2019-2022 | |
| Tela Bio, INC. | $292.41 | 2021-2022 | |
| Stryker Corporation | $176.96 | 2024 | Na, Vsp System, Vsp Cranial, Smartlock |
| Sientra, INC. | $164.36 | 2021 | |
| Axogen | $144.62 | 2021 | |
| Integra Lifesciences Corporation | $20.00 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Shakir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.